NEUKIO BIOTHERAPEUTICS
Startup
NEUKIO BIOTHERAPEUTICS
Description
Neukio Biotherapeutics develops next generation allogenic cell therapies designed for the iPSC-CAR-NK axis, through internal discovery and external collaboration.
Resources
NEUKIO BIOTHERAPEUTICS
Address
CHINA
Contact
Admin@neukio.com
Description
Neukio Biotherapeutics develops next generation allogenic cell therapies designed for the iPSC-CAR-NK axis, through internal discovery and external collaboration.
Resources
Matchmaking
Connect with NEUKIO BIOTHERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways